Journal of Diabetes Research (Jan 2024)

Efficacy and Safety of Ertugliflozin Compared to Placebo in Patients With Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis

A. B. M. Kamrul-Hasan,
Muhammad Shah Alam,
Samir Kumar Talukder,
Mohammad Abdul Hannan,
Deep Dutta,
Lakshmi Nagendra,
Shahjada Selim

Affiliations

A. B. M. Kamrul-Hasan: Department of Endocrinology
Muhammad Shah Alam: Department of Medicine
Samir Kumar Talukder: Department of Endocrinology
Mohammad Abdul Hannan: Department of Endocrinology
Deep Dutta: Department of Endocrinology
Lakshmi Nagendra: Department of Endocrinology
Shahjada Selim: Department of Endocrinology

DOI: https://doi.org/10.1155/2024/5553327
Journal volume & issue: Vol. 2024

Abstract

Conclusion: Ertugliflozin has a good glycemic efficacy and a reassuring safety profile in managing T2D.

Published in Journal of Diabetes Research

ISSN: 2314-6745 (Print); 2314-6753 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology
Website: https://onlinelibrary.wiley.com/journal/1485

About the journal